Switzerland Biotechnology & Medical Research

BioVersys AG (BIOV)

Track

BioVersys AG recorded a single insider purchase totaling 1,839 CHF within the last ninety days. This transaction follows a previous acquisition of 469 shares in late March. Despite a 2.6% decline in stock price over the quarter, these recent buying activities represent the only notable market movements by company insiders during this period.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: BIOV Exchange: SWX

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for BioVersys AG

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Non-Executive Director

Transaction date 14 May 2026

Purchase

Price

21.88

Quantity 75,366

Value CHF787,456

Non-Executive Director

Transaction date 26 Mar 2026

Purchase

Price

415.78

Quantity 58,401

Value CHF4,496,108

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-05-14	2026-05-14	B Purchase	Non-Executive Director	75,366 21.88 CHF787,456	75,366	21.88	CHF787,456
2026-03-26	2026-03-26	B Purchase	Non-Executive Director	58,401 415.78 CHF4,496,108	58,401	415.78	CHF4,496,108